DERM logo

Journey Medical Corporation Common Stock


DERM: Journey Medical Corp is a commercial-stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm, etc.


Show DERM Financials

Consumer Interest
SEC Filings

Recent trades of DERM by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by DERM's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Process for production of glycopyrronium tosylate Jan. 03, 2023
  • Patent Title: Processes for making, and methods of using, glycopyrronium compounds Jun. 07, 2022
  • Patent Title: Compositions and methods for treating rosacea and acne May. 10, 2022
  • Patent Title: Glycopyrrolate salts Apr. 05, 2022
  • Patent Title: Glycopyrrolate salts Apr. 05, 2022
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of DERM in WallStreetBets Daily Discussion


Recent insights relating to DERM

CNBC Recommendations

Recent picks made for DERM stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in DERM

Corporate Flights

Flights by private jets registered to DERM